» Articles » PMID: 27509875

Fenamate NSAIDs Inhibit the NLRP3 Inflammasome and Protect Against Alzheimer's Disease in Rodent Models

Abstract

Non-steroidal anti-inflammatory drugs (NSAIDs) inhibit cyclooxygenase-1 (COX-1) and COX-2 enzymes. The NLRP3 inflammasome is a multi-protein complex responsible for the processing of the proinflammatory cytokine interleukin-1β and is implicated in many inflammatory diseases. Here we show that several clinically approved and widely used NSAIDs of the fenamate class are effective and selective inhibitors of the NLRP3 inflammasome via inhibition of the volume-regulated anion channel in macrophages, independently of COX enzymes. Flufenamic acid and mefenamic acid are efficacious in NLRP3-dependent rodent models of inflammation in air pouch and peritoneum. We also show therapeutic effects of fenamates using a model of amyloid beta induced memory loss and a transgenic mouse model of Alzheimer's disease. These data suggest that fenamate NSAIDs could be repurposed as NLRP3 inflammasome inhibitors and Alzheimer's disease therapeutics.

Citing Articles

Microglial NLRP3 Inflammasomes in Alzheimer's Disease Pathogenesis: From Interaction with Autophagy/Mitophagy to Therapeutics.

Ayyubova G, Madhu L Mol Neurobiol. 2025; .

PMID: 39951189 DOI: 10.1007/s12035-025-04758-z.


Neuroinflammation: A Driving Force in the Onset and Progression of Alzheimer's Disease.

Long C, Fritts A, Broadway J, Brawman-Mintzer O, Mintzer J J Clin Med. 2025; 14(2.

PMID: 39860337 PMC: 11766252. DOI: 10.3390/jcm14020331.


Animal models of Alzheimer's disease: Current strategies and new directions.

Wang Q, Zhu B, Lei P Zool Res. 2024; 45(6):1385-1407.

PMID: 39572020 PMC: 11668949. DOI: 10.24272/j.issn.2095-8137.2024.274.


Role of Thrombosis in Neurodegenerative Diseases: An Intricate Mechanism of Neurovascular Complications.

Beura S, Panigrahi A, Yadav P, Kulkarni P, Lakhanpal V, Singh B Mol Neurobiol. 2024; 62(4):4802-4836.

PMID: 39482419 DOI: 10.1007/s12035-024-04589-4.


Non-coding RNAs as a Critical Player in the Regulation of Inflammasome in Inflammatory Bowel Diseases; Emphasize on lncRNAs.

Salim Abed H, Oghenemaro E, Kubaev A, Jeddoa Z, S R, Sharma S Cell Biochem Biophys. 2024; .

PMID: 39424765 DOI: 10.1007/s12013-024-01585-2.


References
1.
Hua K, Chou J, Ka S, Tasi Y, Chen A, Wu S . Cyclooxygenase-2 regulates NLRP3 inflammasome-derived IL-1β production. J Cell Physiol. 2014; 230(4):863-74. DOI: 10.1002/jcp.24815. View

2.
Heneka M, Carson M, El Khoury J, Landreth G, Brosseron F, Feinstein D . Neuroinflammation in Alzheimer's disease. Lancet Neurol. 2015; 14(4):388-405. PMC: 5909703. DOI: 10.1016/S1474-4422(15)70016-5. View

3.
Desbene C, Malaplate-Armand C, Youssef I, Garcia P, Stenger C, Sauvee M . Critical role of cPLA2 in Aβ oligomer-induced neurodegeneration and memory deficit. Neurobiol Aging. 2011; 33(6):1123.e17-29. DOI: 10.1016/j.neurobiolaging.2011.11.008. View

4.
Youssef I, Florent-Bechard S, Malaplate-Armand C, Koziel V, Bihain B, Olivier J . N-truncated amyloid-beta oligomers induce learning impairment and neuronal apoptosis. Neurobiol Aging. 2007; 29(9):1319-33. DOI: 10.1016/j.neurobiolaging.2007.03.005. View

5.
Sanders M, Parsons M, Howard A, Liu J, Fassio S, Martinez J . Single-cell imaging of inflammatory caspase dimerization reveals differential recruitment to inflammasomes. Cell Death Dis. 2015; 6:e1813. PMC: 4650733. DOI: 10.1038/cddis.2015.186. View